Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 414 (RNA5SP414) is a non-coding pseudogene in the human genome that arose from the reverse transcription and insertion of a 5S ribosomal RNA (rRNA) transcript[3][4]. Pseudogenes like RNA5SP414 lack known protein-coding potential or canonical biological function because they typically accumulate disabling mutations or lack necessary regulatory elements[2][4]. While the parent 5S rRNA is an essential component of the large ribosomal subunit and is involved in the structural organization of the ribosome as well as possible signaling between functional centers[1][5][7], pseudogenes themselves are generally considered non-functional genomic elements[2][3][4]. However, recent research suggests some pseudogenes may have potential regulatory roles or be implicated in disease processes at the RNA level[6]. No specific functional, therapeutic, or biomarker role exists for RNA5SP414, and it is not recognized as a drug or therapeutic target.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 414 (RNA5SP414).